8/11/2009

Colorectal cancer patients with the normal version of the KRAS gene had increased progression-free survival when treated initially with Vectibix and chemotherapy, compared to chemotherapy alone, a clinical study showed. Reported side effects included diarrhea, skin toxicity and low magnesium blood levels.

Full Story:
Reuters

Related Summaries